IDWeek: Ending HIV as an epidemic will demand innovation, inclusion, an expanded workforce — and funding

By on .

Science Speaks is at IDWeek 2019 Oct. 2-6, covering the joint annual meeting of the Infectious Diseases Society of America, Society for Healthcare Epidemiology of America, the HIV Medical Association, and the Pediatric Infectious Diseases Society in Washington, DC.

As the federal Ending the HIV epidemic takes form, experts talk details, challenges: “How do we get there from here?”

WASHINGTON, DC – Nearly four decades into an epidemic that has taken the lives more than 700,000 people in America, still close to 40,000 people in this country are diagnosed with HIV here each year. Half had the virus for at least three years before they knew it. Continued stigma surrounding the HIV, discrimination and institutionalized neglect of populations that include men who have sex with men, people who inject drugs, and immigrants, along with barriers to healthcare, housing, justice, transportation, exacerbate risks of HIV and other illnesses in communities across the country.

The federal Ending the HIV Epidemic initiative will have to confront all of those realities and more to achieve its goal, panelists agreed in a discussion here Friday Ending HIV as an Epidemic: How do we get there from here?

With all of those realities, significant strides in medicine, policy and epidemiology have put the goal of ending America’s longest epidemic within reach, Dr. Tammy Beckham of the Department of Health and Human Services said. And while funding for the initiative, which was to begin in the fiscal year that started Tuesday, remains in the limbo in the absence of a final spending bill, the work of gathering information and resources to put the plan in action has begun, she said. That includes a contract with the makers of Truvada, the original drug approved pre-exposure prophylaxis — or PrEP — to prevent HIV acquisition, to donate, and initially coordinate the distribution of enough doses to ensure that anyone who has a prescription and does not have insurance covering prescription medicines will have access to the drug.

Visits to all of the jurisdictions in the first phase of the plan — which targets 48 counties and seven states across America, as well as the District of Columbia and San Juan, Puerto Rico, have provided feedback on some of the most critical issues, including urgent imperatives to bring services to patients, address needs for housing and transportation, respond to the impacts of disparate sentencing and other inequities, and to engage and employ community members in efforts to ensure they are sustainable.

Also needed, said Dr. Carlos del Rio a physician and professor of medicine at Emory University in Georgia, one of the priority states and home to four of the priority counties all part of the Atlanta metropolitan area where he treats patients, will be a health workforce sufficient to meet the needs of greatly expanded numbers people identified and linked to services.

“I don’t know who will care for them,” Dr. del Rio said, noting a major shortage of HIV physicians. The shortage is even more acute in rural areas, said Dr. Judith Feinberg, a professor of medicine at West Virginia University, and newly elected president of the HIV Medicine Association (which, with the Infectious Diseases Society of America, produces this blog). The impacts of the opioid epidemic have made efforts to prevent and treat HIV transmissions all the more urgent in rural areas, particularly in central Appalachia “the cradle of the opioid epidemic,” she said. Yet, she added, with the exception of Kentucky, no Appalachian states or counties are among the HIV initiatives priority communities.

Dr. Beckham replied that this is the first phase of the 10-year plan. In the meantime, she said, change — or as panelist Dr. John Brooks of the U.S. Centers for Disease Control and Prevention said “disruptive innovation,” will be an essential element.

“If we could have done it the way we were already working,” Dr. Beckham said, “we would have done it,”

One thought on “IDWeek: Ending HIV as an epidemic will demand innovation, inclusion, an expanded workforce — and funding

  1. john

    Yes–great article–we need to change to get something different that what we have always had.

    Surprised that none of the experts of the article mention the need to ensure that at least 90-90-90 or 95-95-95 of people living with HIV-how can we expect to stop the epidemic if hundreds of thousands of people living with HIV in the US are not on successful treatment. The article should mention that by keeping these people alive and healthy we can also stop transmission. PrEP is always the go to answer and it may work to stop new infections for the wealthy and/or switched on people who access it but it will not help people who are already infected. Treatment prevents almost 100% of transmission–why would the US be OK with leaving 40% of people unsuppressed while begging Gilead to lower prices on PrEP? Treatment to prevent illness, death and transmission may already be part of the plan but it is rarely mentioned by experts or the media.

    It is too easy for the Trump administration and its agencies–HHS, CDC and others–to focus on PrEP prevention since it avoids having to tackle the difficult issue of ensuring health care for the poorest and most vulnerable people in US society–health care for all is critical since not everyone will access PrEP and infections will continue unless millions of people start and stay on PrEP. Other countries have achieved universal free access to treatment in their HIV program, achieving well over 90-90-90–some in Africa and others in Europe. If they can do it–why can’t the US do it?

    Even if the funding comes through if the US does not focus on ensuring that people living with HIV access earlier diagnosis and treatment. Trump may not want to treat poor people but in the end he and his minions will realize that without treatment, no amount of PrEP will stop transmission AND keep people alive and healthy. Hopefully there are courageous experts who will speak this truth to power!


Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.